Brexpiprazole has a low risk of dopamine D2 receptor sensitization and inhibits rebound phenomena related to D2 and serotonin 5‐HT2A receptors in rats

Abstract Background Long‐term antipsychotic treatment in patients with schizophrenia can induce supersensitivity psychosis and tardive dyskinesia which is thought to be caused by dopamine D2 receptor sensitization. We evaluated the effects of brexpiprazole on D2 receptor sensitivity after subchronic...

Full description

Saved in:
Bibliographic Details
Main Authors: Naoki Amada (Author), Hitomi Akazawa (Author), Yuta Ohgi (Author), Kenji Maeda (Author), Haruhiko Sugino (Author), Nobuyuki Kurahashi (Author), Tetsuro Kikuchi (Author), Takashi Futamura (Author)
Format: Book
Published: Wiley, 2019-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available